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This diploma thesis deals with the synthesis of new inhibitors of the 
mycobacterial enzyme InhA and inhibitors of acetylcholinesterase and 
butyrylcholinesterase and their potential inhibitory effect against these three enzymes. 
All of the prepared compounds are analogues derived from triclosan, which could be 
convenient candidates as potential drugs for the treatment of tuberculosis and 
neurodegenerative diseases including Alzheimer's disease. 
The theoretical part summarizes facts about tuberculosis including the resistance 
of mycobacteria to antituberculosis drugs and research of new drugs against tuberculosis. 
Also, the cholinergic hypothesis and the investigation of new potential inhibitors of 
cholinesterases are described briefly. The experimental part reports the reactions leading 
to the preparation of designed compounds. The chapter Results and discussion 
summarizes structure-activity relationships. It also discusses the synthesis and its 
complications. 
Eight compounds (two precursors for further syntheses and modifications, two 
final amides, two ureas and two carbamates) were prepared in satisfactory yields. All of 
them were tested for their antimicrobial activity and cholinesterase inhibitory activity. 
The compound N-[5-chloro-2-(2,4-dichlorophenoxy)phenyl]acetamide showed the best 
antimicrobial activity against all three selected mycobacteria at all. It had minimum 
inhibitory concentration of 31.25 mg/L against M. smegmatis, 15.625 mg/L against M. 
aurum and 7.81 mg/L against M. tuberculosis H37Ra, respectively. This compound even 
showed the lowest IC50 value for acetylcholinesterase (48.85 µM) of all the prepared 
compounds and has a better inhibitory effect against acetylcholinesterase than the 
clinically used carbamate drug rivastigmine (56.10 µM). The precursor 5-chloro-2-(2,4-
dichlorophenoxy)aniline ("amino-triclosan") showed the best inhibition of 
butyrylcholinesterase (IC50 of 11.93 µM), which is a better inhibitory activity compared 
to rivastigmine again. Triclosan showed comparable inhibitory activity (11,81±0,04 µM) 
against BuChE to its isoster "amino-triclosan". It was found that triclosan is a mixed 
inhibitor. 
The determination of structure-activity relationships suggests that "amino-
triclosan" analogues are perspective for further studies and investigation of triclosan 
analogues as potential inhibitors of acetylcholinesterase and butyrylcholinesterase and 
for experimental determination of mechanism of action against mycobacteria. 
